Normal and abnormal biology of the beta-amyloid precursor protein.

Few macromolecules have become the object of more intense chemical and biological scrutiny in recent years than has the l3-amyloid precursor protein. This highly conserved and widely expressed integral membrane protein is the focus of a rapidly growing number of studies aimed at its characterization by protein chemical, molecular biological , cell biological , and neuroanatomical methods. The principal reason for this attention is clear. The early promise that a 39-43 residue fragment of I3APP, the amyloid l3-protein (AI3), might play a central role in the pathogenesis of Alzheimer's disease has increasingly been borne out. Although there is still substantial debate about exactly when AI3 becomes involved in Alzheimer's disease and how attractive a therapeutic target it represents , accumulating evidence now points to an early and sometimes causative role in the pathogenetic cascade. I3APP has become a compelling example of the phenomenon of research that begins with a strictly disease-oriented focus giving rise to novel insights about the normal biology of a whole family of macromolecules, in this case about the processing of certain cell surface, single membrane-spanning polypeptides. Here, I review recent information about the normal structure and function of I3APP and how its AI3 fragment contributes to Alzheimer's disease. Such

[1]  T. Mandybur The incidence of cerebral amyloid angiopathy in Alzheimer's disease , 1975, Neurology.

[2]  D. Munoz Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[3]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Hardy,et al.  A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene , 1992, Nature Genetics.

[5]  M J Ball,et al.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.

[6]  S. Shiojiri,et al.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.

[7]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[8]  B. Hyman,et al.  Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor , 1993, Nature Genetics.

[9]  L. Thal,et al.  Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.

[10]  F. Tagliavini,et al.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals , 1988, Neuroscience Letters.

[11]  R. Senior,et al.  The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide. , 1992, The Journal of clinical investigation.

[12]  R. Neve,et al.  The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. , 1990, The Journal of biological chemistry.

[13]  H. Braak,et al.  Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques , 1986, Neuroscience Letters.

[14]  D. Selkoe Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease , 1989, Neurobiology of Aging.

[15]  Carl W. Cotman,et al.  Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.

[16]  D. Stephenson,et al.  Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat , 1992, Brain Research.

[17]  C. Broeckhoven,et al.  Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3 , 1992, Nature Genetics.

[18]  C. Cotman,et al.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.

[19]  H. Vinters,et al.  Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. , 1988, Human pathology.

[20]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[21]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[22]  P. Cras,et al.  Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Eikelenboom,et al.  Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease , 1990, Neuroscience Letters.

[24]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[25]  B. Yankner,et al.  An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types , 1991, Neuroscience Letters.

[26]  J. Growdon,et al.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.

[27]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[28]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[29]  G. Broze,et al.  Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. , 1990, Science.

[30]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[31]  R. Kalaria,et al.  Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders , 1991, Neuropathology and applied neurobiology.

[32]  M. Kidd Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.

[33]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[34]  S. Hirai,et al.  Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. , 1989, The American journal of pathology.

[35]  F. D. de Sauvage,et al.  A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. , 1989, Science.

[36]  J. Weber,et al.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.

[37]  P. Greengard,et al.  Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Wegiel,et al.  Ultrastructural Studies of the Cells Forming Amyloid Fibers in Classical Plaques , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[39]  K. Davis,et al.  Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. , 1987, Archives of general psychiatry.

[40]  I. Nishimoto,et al.  Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go , 1993, Nature.

[41]  C. Cotman,et al.  β-Amyloid protein promotes neuritic branching in hippocampal cultures , 1990, Neuroscience Letters.

[42]  F. Tagliavini,et al.  Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques , 1989, Neuroscience Letters.

[43]  R. Tanzi,et al.  Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Engel,et al.  Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. , 1992, The American journal of pathology.

[45]  D. Selkoe,et al.  Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging , 1988, Brain Research.

[46]  J. Trojanowski,et al.  The disordered neuronal cytoskeleton in Alzheimer's disease , 1992, Current Opinion in Neurobiology.

[47]  P. Cras,et al.  Serial reconstruction of β-protein amyloid plaques: relationship to microvessels and size distribution , 1992, Brain Research.

[48]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.